September 8, 2025
ZEISS Introduces High-Speed TDC Veloce Cutter
At Euretina 2025, the company presented a new vitreoretinal cutter and highlighted updates to its visualization and diagnostic technologies.
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/1t4bgb4a/cover_sept25.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/fs4i103q/cover_sept25.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/0s0ksauu/0925-gp-cover.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/5isnzmog/0725-op-cover-final-1.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/upwdjelf/0725_cover_final.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/aqbjxwjw/pp-cover.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/npjdtl1w/cp_november_cover.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/mvqdq2hc/nrp_cover_october_2024.jpg
September 8, 2025
At Euretina 2025, the company presented a new vitreoretinal cutter and highlighted updates to its visualization and diagnostic technologies.
September 8, 2025
In data presented at Euretina 2025, more than half of Asian patients with polypoidal choroidal vasculopathy required fewer injections after a year of Vabysmo therapy.
September 5, 2025
Phase 2 results presented at Euretina showed reduced injection frequency as well as improvements in retinal structure and visual function.
September 5, 2025
The European Society of Retina Specialists welcomed more than 10,000 participants to its 25th annual congress.
September 5, 2025
Updated phase 1/2 data presented at Euretina suggest AAVantgarde's AAVB-081 may improve measures of vision.
September 5, 2025
European retina experts call for multimodal imaging, early specialist referral, and strategies that address the broader impact of geographic atrophy on patients’ quality of life.
September 4, 2025
The dual-function phaco-vitrectomy device has not yet received regulatory clearance.
September 4, 2025
Data presented at the Euretina congress in Paris highlight transferrin’s potential role in dry AMD progression.
September 4, 2025
Patients with diabetic macular edema who received the Iluvien implant needed less than half as many injections as those treated with aflibercept alone.
September 4, 2025
Data on patients with DME, reported at Euretina, show BCVA gains and improvement in retinal thickness at 12 weeks.
September 4, 2025
The award, established in memory of the late Ramin Tadayoni, MD, PhD, and presented at Euretina, supports talented retina researchers with a significant grant.